$117.586,00
10% de descuento pagando con Transferencia o depósito
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

The Guest Editors have assembled top international experts to present clinical reviews on the most current data being utilized in the diagnosis, treatment, and management of HBV. In fact, the most recent EASL meeting fndings are included in many of the articles. Special focus is given to Results of Treatment of Chronic Hepatitis B with Pegylated Interferon; Impact of Therapy on the Long Term Outcome of Chronic Hepatitis B; HBsAg Quantification: Clinical; HBV Infection and Hepatocellular Carcinoma; HIV-HBV Co-Infection: An Update; Hepatitis Delta: The Rediscovery; and Treatment of Patients with HBV Related Decompensated Cirrhosis and Liver Transplanted Patients

1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Contributors - p. 4 5. Forthcoming Issues - p. 6 6. An Update in the Management of Chronic Hepatitis B - p. 7 7. HBV Infection and Hepatocellular Carcinoma - p. 8 8. HBsAg Quantification to Predict Natural History and Treatment Outcome in Chronic Hepatitis B Patients - p. 18 9. Impact of Therapy on the Long-Term Outcome of Chronic Hepatitis B - p. 26 10. Results of Treatment of Chronic Hepatitis B with Pegylated Interferon - p. 32 11. Long-term Results of Treatment with Nucleoside and Nucleotide Analogues (Entecavir and Tenofovir) for Chronic Hepatitis B - p. 43 12. Treatment of Patients with HBV-related Decompensated Cirrhosis and Liver Transplanted Patients - p. 46 13. Hepatitis Delta - p. 58 14. Hepatitis B in HIV-Infected Patients - p. 65 15. Index - p. 72

No hay muestra disponible

No hay ficha técnica disponible

Descripcion
Descripción

The Guest Editors have assembled top international experts to present clinical reviews on the most current data being utilized in the diagnosis, treatment, and management of HBV. In fact, the most recent EASL meeting fndings are included in many of the articles. Special focus is given to Results of Treatment of Chronic Hepatitis B with Pegylated Interferon; Impact of Therapy on the Long Term Outcome of Chronic Hepatitis B; HBsAg Quantification: Clinical; HBV Infection and Hepatocellular Carcinoma; HIV-HBV Co-Infection: An Update; Hepatitis Delta: The Rediscovery; and Treatment of Patients with HBV Related Decompensated Cirrhosis and Liver Transplanted Patients

1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Contributors - p. 4 5. Forthcoming Issues - p. 6 6. An Update in the Management of Chronic Hepatitis B - p. 7 7. HBV Infection and Hepatocellular Carcinoma - p. 8 8. HBsAg Quantification to Predict Natural History and Treatment Outcome in Chronic Hepatitis B Patients - p. 18 9. Impact of Therapy on the Long-Term Outcome of Chronic Hepatitis B - p. 26 10. Results of Treatment of Chronic Hepatitis B with Pegylated Interferon - p. 32 11. Long-term Results of Treatment with Nucleoside and Nucleotide Analogues (Entecavir and Tenofovir) for Chronic Hepatitis B - p. 43 12. Treatment of Patients with HBV-related Decompensated Cirrhosis and Liver Transplanted Patients - p. 46 13. Hepatitis Delta - p. 58 14. Hepatitis B in HIV-Infected Patients - p. 65 15. Index - p. 72

Indice
Autores
Muestra

No hay muestra disponible

Ficha Técnica

No hay ficha técnica disponible